A Hybrid-Targeting Nanoparticle for Penetrable Delivery of Temozolomide to Enhance Glioblastoma Therapy

Journal:

Nano Letters

Published:

2025-05-14

DOI:

10.1021/acs.nanolett.5c01609

Affiliations:

8

Authors:

8

Go to article

Institutions	Authors	Share
China State Institute of Pharmaceutical Industry (CSIPI), China	1.500000	0.19
Shanxi University of Traditional Chinese Medicine, China	1.500000	0.19
Shaanxi Traditional Chinese Medicine Hospital, China	1.500000	0.19
Nanjing University of Chinese Medicine (NJUCM), China	1.250000	0.16
Shanxi Provincial People's Hospital, China	1.000000	0.13
State Key Laboratory of Drug Research (SKLDR), SIMM CAS, China	0.750000	0.09
Yantai Institute of Pharmaceutical Science, China	0.250000	0.03
Bohai Rim Advanced Research Institute for Drug Discovery, China	0.250000	0.03

Interested in Pharmacology and Pharmaceutical Sciences?